Treatment strategy for heart failure patients with guideline-directed medical therapy intolerance: a real-world prospective study

31 August 2024 (18:00 - 18:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Junlong Chen

Chongqing (China)

7 More presentations in this session

Presentation thumbnail

Treatment with flozins across the whole spectrum of heart failure in Poland between February 2022 and June 2023 based on Heart Failure Observational Study by Polish Cardiac Society..

Doctor R. Morawiec (Lodz, PL)

Abstract Slides Video

Presentation thumbnail

Feasibility and efficacy of acetazolamide in the treatment of acute decompensated heart failure

Doctor Y. Iemura (Kawagoe, JP)

Abstract Slides Video

Presentation thumbnail

Efficacy of acetazolamide as adjunct therapy in improving fluid management in patients with acute congestive heart failure: a systematic review and meta-analysis of randomized controlled trials

Doctor I. Tolentino Narciso (Montes Claros, BR)

Abstract Slides Video

Presentation thumbnail

The efficacy of IV iron in anemic heart failure patients: a systemic review and meta-analysis of randomised controlled trials.

Doctor A. Al Qurm (JO)

Abstract Slides Video

Presentation thumbnail

Effects of anakinra on patients with heart failure below and above 60 years of age

Doctor M. Golino (Jacksonville, US)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure therapy: new insights

The Event

Event poster

ESC Congress 2024

31 August 2024 18:00 CET

You may be interested in

Congress Presentation

Did we forget ARNI in the era of SGLTi?

Congress Presentation

GDMT in HFrEF: a complete story or a partial narrative?

Congress Presentation

Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources